Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


[History of the anatomical and clinical autopsy].

Diallo-Danebrock R, Abbas M, Groß D, Kellner U.

Pathologe. 2018 Jul 30. doi: 10.1007/s00292-018-0461-7. [Epub ahead of print] Review. German.


BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.

Schouten PC, Gluz O, Harbeck N, Mohrmann S, Diallo-Danebrock R, Pelz E, Kruizinga J, Velds A, Nieuwland M, Kerkhoven RM, Liedtke C, Frick M, Kates R, Linn SC, Nitz U, Marme F.

Int J Cancer. 2016 Aug 15;139(4):882-9. doi: 10.1002/ijc.30078. Epub 2016 May 5.


MRI features of intraductal papilloma of the breast: sheep in wolf's clothing?

Kurz KD, Roy S, Saleh A, Diallo-Danebrock R, Skaane P.

Acta Radiol. 2011 Apr 1;52(3):264-72. doi: 10.1258/ar.2011.100434.


Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.

Gluz O, Wild P, Liedtke C, Kates R, Mendrik H, Ehm E, Artinger V, Diallo-Danebrock R, Ting E, Mohrmann S, Poremba C, Harbeck N, Nitz U, Hartmann A, Gaumann A.

Breast Cancer Res Treat. 2011 Apr;126(3):643-51. doi: 10.1007/s10549-011-1377-6. Epub 2011 Feb 12.


Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.

Gluz O, Mengele K, Schmitt M, Kates R, Diallo-Danebrock R, Neff F, Royer HD, Eckstein N, Mohrmann S, Ting E, Kiechle M, Poremba C, Nitz U, Harbeck N.

J Clin Oncol. 2009 Dec 20;27(36):6144-51. doi: 10.1200/JCO.2008.19.6261. Epub 2009 Nov 9.


Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.

Gluz O, Wild P, Meiler R, Diallo-Danebrock R, Ting E, Mohrmann S, Schuett G, Dahl E, Fuchs T, Herr A, Gaumann A, Frick M, Poremba C, Nitz UA, Hartmann A.

Int J Cancer. 2008 Sep 15;123(6):1433-8. doi: 10.1002/ijc.23628.


[Prognostic and predictive impact of protein expression profiling in high risk breast cancer patients treated with high-dose chemotherapy].

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Gabbert HE, Nitz U, Poremba C.

Verh Dtsch Ges Pathol. 2007;91:187-96. German.


Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.

Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, Dirksen U, Lanvers-Kaminsky C, Juergens H, Herrero D, Stegmaier S, Koscielniak E, Eggert A, Nathrath M, Gosheger G, Schneider DT, Bury C, Diallo-Danebrock R, Ottaviano L, Gabbert HE, Poremba C.

Eur J Cancer. 2008 Mar;44(5):699-709. doi: 10.1016/j.ejca.2008.01.020. Epub 2008 Feb 21.


Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.

Gluz O, Nitz UA, Harbeck N, Ting E, Kates R, Herr A, Lindemann W, Jackisch C, Berdel WE, Kirchner H, Metzner B, Werner F, Schütt G, Frick M, Poremba C, Diallo-Danebrock R, Mohrmann S; West German Study Group.

Ann Oncol. 2008 May;19(5):861-70. doi: 10.1093/annonc/mdm551. Epub 2008 Jan 3.


Nephron-sparing surgery of a low grade renal cell carcinoma in a renal allograft 12 years after transplantation.

Mundel TM, Schaefer KL, Colombo-Benkmann M, Dietl KH, Diallo-Danebrock R, Senninger N.

Cancer Biol Ther. 2007 Nov;6(11):1700-3. Epub 2007 Oct 13.


Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1.

Rody A, Holtrich U, Gaetje R, Gehrmann M, Engels K, von Minckwitz G, Loibl S, Diallo-Danebrock R, Ruckhäberle E, Metzler D, Ahr A, Solbach C, Karn T, Kaufmann M.

Clin Cancer Res. 2007 Feb 15;13(4):1115-22.


Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.

Diallo-Danebrock R, Ting E, Gluz O, Herr A, Mohrmann S, Geddert H, Rody A, Schaefer KL, Baldus SE, Hartmann A, Wild PJ, Burson M, Gabbert HE, Nitz U, Poremba C.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):488-97.


Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci.

Domagk D, Schaefer KL, Eisenacher M, Braun Y, Wai DH, Schleicher C, Diallo-Danebrock R, Bojar H, Roeder G, Gabbert HE, Domschke W, Poremba C.

Oncol Rep. 2007 Feb;17(2):399-407.


Supplemental Content

Loading ...
Support Center